Financial Ratios

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE215.452.75 (+1.29 %)
PREV CLOSE ( ) 212.70
OPEN PRICE ( ) 214.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18281
TODAY'S LOW / HIGH ( )212.80 216.95
52 WK LOW / HIGH ( )132.75 307.8
NSE215.612.68 (+1.26 %)
PREV CLOSE( ) 212.93
OPEN PRICE ( ) 211.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 258300
TODAY'S LOW / HIGH( ) 211.20 216.99
52 WK LOW / HIGH ( )133 307.98
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)-4.87-3.75-1.94-14.422.46
   CEPS(Rs)1.612.386.99-5.4111.42
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)258.46262.39269.88298.13305.66
   Tax Rate(%)25.8238.8063.43-39.5830.54
Margin Ratios
   Core EBITDA Margin(%)2.081.9311.02-26.3529.89
   EBIT Margin(%)-10.63-9.51-15.03-63.8217.65
   Pre Tax Margin(%)-31.46-23.90-27.17-80.889.55
   PAT Margin (%)-23.34-14.62-9.94-112.896.63
   Cash Profit Margin (%)7.709.2735.75-42.3330.85
Performance Ratios
   ROA(%)-1.45-1.10-0.55-3.900.66
   ROE(%)-1.87-1.41-0.68-4.780.80
   ROCE(%)-0.75-0.81-0.93-2.421.89
   Asset Turnover(x)0.060.080.060.030.10
   Sales/Fixed Asset(x)0.130.170.130.090.25
   Working Capital/Sales(x)-10.3950.261.431.044.03
Efficiency Ratios
   Fixed Capital/Sales(x)7.685.967.6711.753.99
   Receivable days184.2696.32109.85240.3286.44
   Inventory Days196.40172.08226.96362.63137.09
   Payable days316.66148.22198.71262.47163.79
Valuation Parameters
   PER(x)0.000.000.000.0021.83
   PCE(x)146.6052.3826.49-20.164.69
   Price/Book(x)0.910.480.690.370.18
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)12.866.1510.9110.762.30
   EV/Core EBITDA(x)60.2541.3333.47159.635.48
   EV/EBIT(x)-120.89-64.70-72.56-16.8613.01
   EV/CE(x)0.920.530.620.380.25
   M Cap / Sales11.294.869.478.531.45
Growth Ratio
   Net Sales Growth(%)-18.6831.2953.06-65.515.69
   Core EBITDA Growth(%)16.57-40.02640.00-94.45-8.42
   EBIT Growth(%)9.0616.9363.96-224.76-20.66
   PAT Growth(%)-29.79-93.2186.53-687.07-31.23
   EPS Growth(%)-29.79-93.2186.53-687.45-29.25
Financial Stability Ratios
   Total Debt/Equity(x)0.130.140.120.110.12
   Current Ratio(x)0.951.011.391.361.23
   Quick Ratio(x)0.670.731.031.010.89
   Interest Cover(x)-0.51-0.66-1.24-3.742.18
   Total Debt/Mcap(x)0.140.300.180.310.66

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.